The company’s Aurangabad facility underwent inspection in April 2017
Lupin has received notification that the inspection carried out by the US FDA in April 2017 at its Aurangabad facility is now closed and the agency has issued an Establishment Inspection Report (EIR). This closes all outstanding US FDA inspections at Lupin’s Aurangabad facility.
- Advertisement -
Comments are closed.